Drugs and Devices
by Jenna Ogilvie | Jul 27, 2020 | Commentary, Perspectives
When my brother told me he had been diagnosed with COVID-19, I was scared. My memory immediately jumped to visions of his childhood struggles with asthma, which he described as having an ever-tightening chain around his chest. I thought of intubated COVID-19...
by Jenna Ogilvie | Oct 28, 2019 | Commentary, Perspectives
Introduction One-third of the US population has health literacy levels that are basic or below basic [1]. This statistic, while surprising, is not unique to the United States: limited health literacy impacts access to appropriate health-related services around...
by Jenna Ogilvie | Sep 30, 2019 | Discussion Paper, Perspectives
Introduction Cell-, gene-, and tissue-based advanced therapeutic products, referred to in this paper as “cell and gene therapy” (CGT) products, have the potential to address many unmet medical needs. These products are commonly discovered and developed in...
by Jenna Ogilvie | Sep 9, 2019 | Commentary, Perspectives
Those working on changing the course of the opioid crisis cannot afford to overlook simple solutions that could bring timely, positive results. Changing the policies that impact buprenorphine prescribing could have immediate impacts on access to...
by Jenna Ogilvie | Dec 17, 2018 | Discussion Paper, Perspectives
Introduction Breast cancer is the most common malignancy among women in the United States, with over 260,000 new cases and over 40,000 deaths estimated to occur in 2018 [1]. Although most breast cancers are diagnosed with disease localized to the breast or...
Page 1 of 812345...»Last »
